GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3626 - 3650 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgM Patient 3 11 mild
G90223GH
178
IgM Patient 3 4 mild
G90223GH
214
IgA Patient 4 12 mild
G90223GH
356
IgG Patient 4 12 mild
G90223GH
48
IgM Patient 4 12 mild
G90223GH
125
IgA Patient 1 10 moderate
G90562PB
388
IgA Patient 1 22 moderate
G90562PB
394
IgA Patient 1 6 moderate
G90562PB
336
IgG Patient 1 10 moderate
G90562PB
2569
IgG Patient 1 22 moderate
G90562PB
2953
IgM Patient 1 10 moderate
G90562PB
99
IgM Patient 1 22 moderate
G90562PB
122
IgG Patient 1 6 moderate
G90562PB
2317
IgM Patient 1 6 moderate
G90562PB
85
IgA Patient 2 15 mild
G90562PB
262
IgA Patient 2 24 mild
G90562PB
296
IgG Patient 2 15 mild
G90562PB
35
IgG Patient 2 24 mild
G90562PB
35
IgM Patient 2 15 mild
G90562PB
67
IgA Patient 2 3 mild
G90562PB
285
IgG Patient 2 3 mild
G90562PB
38
IgM Patient 2 24 mild
G90562PB
88
IgM Patient 2 3 mild
G90562PB
82
IgA Patient 3 -180 mild
G90562PB
314
IgA Patient 3 11 mild
G90562PB
681

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024